Additionally, only 9.52% of cancers that highly expressed the top-ranked five TFs of scSTAR-TF-C1 had significantly worse OS, while 19.05% of cancers had significantly worse OS predicted by the top-ranked five TFs of scSTAR-TF-C2 (Figure 8D). This evidence concerns the gene TF and cancer.